Your trusted adviser for R&D Tax Credits and R&D Grants
Myriad is proud to announce that 4 of our clients who applied for the Disruptive Technologies Innovation Fund were all approved on Monday 10th December.
Myriad is proud to announce that four of our clients who applied for the Disruptive Technologies Innovation Fund were approved on Monday, December 10th.
With a combined grant value of €14.9m, this will provide a major boost to the MedTech and Cellular Therapy communities in Galway.
The first 27 projects from Ireland’s €500m Disruptive Technologies Innovation Fund (DTIF) were announced this week and will receive a combined €75m in support.
Marc Greatrex, Director of Grants at Myriad commented the success of these applications was a testament to the strength of concepts with the passion, drive and commitment of the SMEs in Galway “We are absolutely thrilled and humbled to have 4 out of 4 applications accepted by the DTIF, we were always hopeful and glad we could help these consortia secure the funding. The technologies they're developing will have a major impact on patients and on the Irish National Strategic Outcomes in the coming years”
The projects include a scheme to help communities generate their own electricity, new treatments for sepsis, a support system for coastal flooding and advanced 3D printing of medical implants.
A mid-2026 recap of every EIC funding scheme: what's closed, what's still open, current deadlines, and what the results so far mean for Irish applicants.
The EIC's Advanced Innovation Challenges pilot offers up to €2.8 million in deep tech funding. See how the two-stage model works and what the first call revealed.
EIC Accelerator Q1 2026: 38 companies funded from 87 interviewed, a record 44% interview-to-win rate. What the data means for Irish applicants.
Please contact us to discuss how working with Myriad can maximise and secure R&D funding opportunities for your business.
Contact us
info@myriadassociates.ie